![Marc M. P. de Garidel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc M. P. de Garidel
Directeur Général chez
ABIVAX
Fortune : 149 M $ au 30/06/2026
Profil
Marc M. P. de Garidel est un homme d'affaires français qui a fondé le Leem et qui a été à la tête de 11 entreprises différentes. Il occupe le poste de président non exécutif d'Ipsen SA, de président d'Ipsen Pharma SAS (une filiale d'Ipsen SA), de président de G5, de président de Vectorlab GmbH et de directeur général et administrateur d'AZTherapies, Inc. Il est également membre du conseil d'administration de la Fédération européenne des industries pharmaceutiques, de l'Innovative Medicines Initiative et de la Société des Membres de la Légion d'Honneur. Il est également professeur à l'ESSEC Business School et professeur à l'ESCP Europe Campus Paris. Au cours de sa carrière, il a occupé les postes de président non exécutif de PROMETHERA Biosciences SA, de président et vice-président de European Biopharmaceutical Enterprises, de directeur financier d'Eli Lilly & Co, de vice-président international d'Amgen, Inc. et de président de Suraypharm SAS, de président et directeur général d'Ipsen Pharma SAS, de directeur général et administrateur de Corvidia Therapeutics, Inc. et de président du Leem. Il a obtenu un diplôme de premier cycle de l'École Spciale des Travaux Publics, un diplôme d'études supérieures de la Thunderbird School of Global Management et un MBA de la Harvard Business School.
Détentions connues dans des sociétés publiques
Postes actifs de Marc M. P. de Garidel
| Sociétés | Poste | Début |
|---|---|---|
| IPSEN | Président | 22/11/2010 |
| CINCOR PHARMA, INC. | Directeur Général | - |
| ABIVAX | Directeur Général | 05/05/2023 |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs | Directeur/Membre du Conseil | 01/07/2020 |
ESCP Europe Campus Paris
 ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Société des Membres de la Légion d'Honneur | Directeur/Membre du Conseil | - |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Directeur/Membre du Conseil | 18/12/2014 |
Anciens postes connus de Marc M. P. de Garidel
| Sociétés | Poste | Fin |
|---|---|---|
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for Alzheimer's disease | Directeur Général | 01/04/2021 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Marc M. P. de Garidel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Thunderbird School of Global Management
 Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for Alzheimer's disease | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Mayroy SA
 Mayroy SA Financial ConglomeratesFinance Provides investment services | Finance |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESCP Europe Campus Paris
ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ecole Spéciale des Travaux Publics
 Ecole Spéciale des Travaux Publics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Leem | |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Develops gene expression biomarkers for transplantation and auto-immune disorders | Commercial Services |
PX Therapeutics SA
 PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Manufactures and develops biotherapeutic products | Commercial Services |
Pharmaxon SAS
 Pharmaxon SAS Pharmaceuticals: MajorHealth Technology Discovers, develops and markets therapeutic drugs controlling cell mobility | Health Technology |
Pharnext SA
 Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Health Technology |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Suraypharm SAS (Boulogne-Billancourt)
 Suraypharm SAS (Boulogne-Billancourt) Financial ConglomeratesFinance Functions as investment fund | Finance |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade Operates as pharmaceutical industry | Retail Trade |
G5 | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Société des Membres de la Légion d'Honneur | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Galenica AG
 Galenica AG Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals and healthcare products | Distribution Services |
Vectorlab GmbH | |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs | Health Technology |
G5 Santé | |
MDG Health GmbH |
